Last reviewed · How we verify
NCT05575908: Expert@Work
Expert@Work - Effectiveness of a Digital Expert Team on Return to Work
NA trial testing Digital expert team in Musculoskeletal Diseases in 170 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2025
Quick facts
| Lead sponsor | St. Olavs Hospital |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 170 |
| Start date | 13 October 2022 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2026 |
| Sites | 4 locations across Norway |
Drugs / interventions tested
- Digital expert team
Conditions studied
- Musculoskeletal Diseases — all drugs for Musculoskeletal Diseases →
- Mental Disorder — all drugs for Mental Disorder →
Sponsor
St. Olavs Hospital
Who can join
Adults 18 to 60, any sex, with Musculoskeletal Diseases or Mental Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Long-term sick leave is a challenge in Norway, and the healthcare and labor- and welfare services are often not coordinated in helping the sick-listed employees return to work. In this study, the investigators want to evaluate the effectiveness of an intervention where an expert team provides advice for an individualized patient pathway based on information from a digital questionnaire and a video meeting with the sick-listed employee and the participant's general practitioner. The patient pathway should include both healthcare and labor- and welfare services measures. Sick-listed patients with musculoskeletal- and/or common mental disorders are invited to join the study. They will receive a digital questionnaire and be randomized to either treatment as usual or personalized advice from an expert team. The team will be put together based on the response from the individual's questionnaire. The investigators will evaluate the effect on return to work and the use of health care services 12 months after the intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05575908
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Musculoskeletal Diseases
Currently open trials in the same condition.
- NCT07324655 — Association Between Office Ergonomics, Work Organization, and Musculoskeletal Complaints in Medical Secretaries · recruiting
- NCT07004478 — Turkish Adaptation Study of the Generic Functional Index · recruiting
- NCT06461000 — EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey · recruiting
- NCT07088965 — Musculoskeletal Disorders of Postgraduate Dentistry Students and Specialist Dentists · recruiting
- NCT06175871 — New Clinical Rehabilitation Approach for the Management of Falls Risks · NA · recruiting
Other St. Olavs Hospital trials
Trials by the same sponsor.
- NCT07331766 — Collaboratory Treatment Pathway for Chronic Pain Patients. · NA · enrolling by invitation
- NCT07305025 — Pelvic Pain Electro-Acupuncture · NA · not yet recruiting
- NCT07245264 — Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH) · Phase 2, PHASE3 · recruiting
- NCT07180433 — Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer · NA · not yet recruiting
- NCT06854861 — Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes · Phase 1, PHASE2 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05575908 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Olavs Hospital
- Last refreshed: 16 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05575908.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing